InvestSMART

Invion Limited (ASX: IVX) - Announcements

- Current share price for IVX : $0.035

ASX company news and announcements for Invion Limited (IVX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Invion Limited (IVX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Invion Limited (IVX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Invion Limited (IVX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$4 Notification regarding unquoted securities - IVX 22 Jun 2026 10:55AM $0.043 $0.035 fallen by 18.60%
$4 Application for quotation of securities - IVX 22 Jun 2026 10:52AM $0.043 $0.035 fallen by 18.60%
$4 Global PDT Leader Dr Colin Hopper Appointed Clinical Advisor 22 Jun 2026 9:24AM $0.043 $0.035 fallen by 18.60%
$4 Change of Directors' Interest Notices x 3 19 Jun 2026 10:48AM $0.041 $0.035 fallen by 14.63%
$4 Notification regarding unquoted securities - IVX 16 Jun 2026 4:14PM $0.043 $0.035 fallen by 18.60%
$4 Notification regarding unquoted securities - IVX 12 Jun 2026 3:03PM $0.044 $0.035 fallen by 20.45%
$4 Notification regarding unquoted securities - IVX 12 Jun 2026 3:01PM $0.044 $0.035 fallen by 20.45%
$4 Notification regarding unquoted securities - IVX 12 Jun 2026 2:54PM $0.044 $0.035 fallen by 20.45%
$4 Application for quotation of securities - IVX 12 Jun 2026 2:45PM $0.044 $0.035 fallen by 20.45%
$4 Results of Extraordinary General Meeting 29 May 2026 5:10PM $0.044 $0.035 fallen by 20.45%
$4 Photosoft Platform Expands to Eye Diseases Via Partnership 19 May 2026 9:21AM $0.051 $0.035 fallen by 31.37%
$4 Correction to Appendix 3Y - Alistair Bennallack 11 May 2026 4:25PM $0.057 $0.035 fallen by 38.60%
$4 Notification of cessation of securities - IVX 1 May 2026 2:40PM $0.062 $0.035 fallen by 43.55%
$4 Appendix 4C and Quarterly Activities Report - March 2026 30 Apr 2026 11:40AM $0.062 $0.035 fallen by 43.55%
$4 Notice of General Meeting/Proxy Form 28 Apr 2026 10:54AM $0.063 $0.035 fallen by 44.44%
$4 Bionnova 2026 Investor Presentation 22 Apr 2026 8:51AM $0.061 $0.035 fallen by 42.62%
$4 Skin Cancer Trial Moves to BCC With More Encouraging Signals 21 Apr 2026 9:46AM $0.061 $0.035 fallen by 42.62%
$4 Appendix 3Y Clarification 20 Apr 2026 12:19PM $0.061 $0.035 fallen by 42.62%
$4 Change of Director's Interest Notice - Thian Chew 20 Apr 2026 12:17PM $0.061 $0.035 fallen by 42.62%
$4 Change of Substantial Holding 8 Apr 2026 11:04AM $0.063 $0.035 fallen by 44.44%
$4 Proposed issue of securities - IVX 23 Mar 2026 11:09AM $0.077 $0.035 fallen by 54.55%
$4 Proposed issue of securities - IVX 23 Mar 2026 11:06AM $0.077 $0.035 fallen by 54.55%
$4 Proposed issue of securities - IVX 23 Mar 2026 11:06AM $0.077 $0.035 fallen by 54.55%
$4 Proposed issue of securities - IVX 23 Mar 2026 11:04AM $0.077 $0.035 fallen by 54.55%
$4 Proposed issue of securities - IVX 18 Mar 2026 4:48PM $0.078 $0.035 fallen by 55.13%

1 - 25 of 711 results

Page 1 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.